1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged NeutropeniaCytopenia, Hemic and Lymphatic Diseases, Neoplasms by Site, agranulocytosis, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukocyte disorder, leukopenia, neoplasm, neutropeniaRecruitingPhase 22026-04-16NCT05537896